Navigation Links
European Integrated Structural Biology Infrastructure launching
Date:2/23/2012

Major transformations in biomedical science are on the horizon with the establishment of the world-class Integrated Structural Biology Infrastructure (Instruct) in support of European biomedical research.

The European Strategy Forum of Research Infrastructures (ESFRI) is involved in establishing about 40 such infrastructures, seven of them in biomedical sciences. Instruct is one such biomedical project, whose aim is to provide pan-European user access to state-of-the-art equipment, technologies and manpower in cellular structural biology. This will allow Europe to maintain a competitive edge and play a leading role in this vital research area.

The Weizmann Institute of Science, together with Tel Aviv University, has been chosen as one of the seven Core Centres, joining prestigious institutions in the UK, Italy, France and Germany.

"Structural Biology is a scientific area in which Israeli scientists have been leading for many years, as evidenced by Weizmann Institute's Prof. Ada Yonath, who won a Nobel Prize in 2009 for her pioneering work on solving the structure of ribosomes," says the Institute's Prof. Joel Sussman, Director of Israel's Instruct Core Centre.

Crucial to understanding how the living cell functions is knowledge of the three-dimensional structures of its proteins and nucleic acids, how these interact with one another, and their arrangement and dynamics within the cell. But no single discipline alone is able to decipher this. "In addition to the Weizmann Institute having developed world-class research programs in several of the disciplines relevant to Instruct, including electron microscopy, mass spectroscopy, X-ray crystallography, NMR, bioinformatics and structural proteomics, the Israel Structural Proteomics Center (ISPC) has played a synergistic role in integrating and coordinating all these various disciplines," says Sussman. The ISPC was established by scientists from the Weizmann Institute, with Sussman as its director, in order to increase the efficiency of protein structure determination.

Mirroring the philosophy of the ISPC, Instruct will merge the information obtained by the various structural biology methods and techniques in order to provide a dynamic picture of key cellular processes, both in vivo and in vitro, on all scales from individual macromolecules, through complexes and organelles to the whole cell. This knowledge will permit major advances in understanding and treating diseases.

"Instruct will allow laboratories throughout Europe to gain ready access to the most advanced facilities, technologies and methodologies. Israeli scientists and their European counterparts will now have access to facilities they could only have dreamed of before," says Weizmann Institute's Prof. Gideon Schreiber, Deputy Director of Israel's Instruct Core Centre, as well as of the ISPC. "We hope this core centre will stimulate new collaborative research projects between laboratories throughout Europe with the Weizmann Institute and with other Israeli institutions, and also attract more graduate students, postdoctoral fellows and visiting scientists from all over the world."

Instruct will formally be launched at a signing ceremony in Brussels on 23rd February, 2012, and Weizmann Institute Vice President Prof. Haim Garty will be signing on behalf of the Weizmann Institute, Tel Aviv University and the State of Israel.


'/>"/>

Contact: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science
Source:Eurekalert

Related biology news :

1. MDC researcher Zsuzsanna Izsvák receives advanced European research grant
2. EASL publishes first European Clinical Practice Guidelines for Wilsons disease
3. European Research Council supports search for regulators of tissue damage
4. European Geosciences Union General Assembly, April 22-27, 2012, Vienna, Austria
5. Cell Therapeutics, Inc. Expects That the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) May Issue an Opinion on the Marketing Authorization Application ("MAA") on Pixuvri™ in Mid-February
6. European mountain vegetation shows effects of warmer climate
7. DTU is participating in a European network on measurement of greenhouse gases
8. Register now for the European Congress on Osteoporosis & Osteoarthritis in Bordeaux
9. UK invests £75 million in European research infrastructure to support knowledge-based economy
10. EMBO awards Installation Grants to 7 European scientists
11. How does a plant survive with few mates or pollinators? A European herb has figured out its own way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):
(Date:8/21/2017)... (PRWEB) , ... August 20, 2017 , ... ... Journal of Biomedical Optics (JBO) starting 1 January 2018. The journal is published ... Biomedical Optics publishes papers on the use of modern optical technology for improved ...
(Date:8/21/2017)... ... August 21, 2017 , ... The team at ... webinar, in which attendees will learn about the assembly and topological architecture of ... an overview of the development and validation of new high-quality recombinant monoclonal antibodies, ...
(Date:8/17/2017)... ... August 17, 2017 , ... ... and personalized medicine, today announced the launch of a new breast cancer monitoring ... study’s goal is to evaluate the potential for early detection of recurrent breast ...
(Date:8/16/2017)... ... August 16, 2017 , ... Today, 3Bar ... has secured $2M in funding from an impressive group of investors, including Rev1 ... Thrive Fund. With this investment, 3Bar is broadening availability of its groundbreaking offering ...
Breaking Biology Technology: